Worldwide News

White blood cells called monocytes released into the blood from bone marrow have abnormal features in people who have COVID-19. This is according to a new study by University of Manchester immunologists at the Lydia Becker Institute. The team from the Coronavirus Immune Response and Clinical Outcome (CIRCO) consortium says the abnormalities are greater in […]

Relation Therapeutics, a drug development company driven by data science and machine learning (ML), has announced Project RE, which will use technology to idenitfy of repurposed drug combinations as potential therapeutic candidates for COVID-19. Project RE will focus on finding therapies to tackle viral entry and replication and is co-led between Mila (Quebec AI Institute) […]

Avacta is planning to launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19. Enzyme linked immunosorbent assays (ELISAs) are very common research tools used to detect and quantify a target of interest in a range of samples. Using the same Affimer reagents that […]

CSL has signed an agreement with the Australian government for the supply of 51 million doses of the University of Queensland’s (UQ) COVID-19 vaccine candidate (V451). In a separate agreement with AstraZeneca it will also manufacture the Oxford University candidate (AZD1222), should clinical trials of both prove successful. The total number of vaccines ordered by […]

The AstraZeneca Oxford University vaccine trial has been paused due to illness in a participant. The much-publicised vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody response within 28 days. As part of the ongoing randomised, controlled clinical […]

CN Bio has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery. It is now collaborating with Imperial College London. The research will harness CN Bio’s Liver-on-Chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development. […]

Dotmatics’ eln.online is a quick start version of its Electronic Laboratory Notebook (ELN). Designed for research organisations at an early stage in their development, eln.online is a new version of the company’s existing ELN Studies Notebook. According to Dotmatics the software can be easily set up. It enables search and capture of experimental data in […]

Scenic Biotech has entered into a multi-year strategic collaboration with Genentech to discover, develop and commercialise novel therapeutics that target genetic modifiers. Genentech is a member of the Roche Group. Genetic modifiers are genes that counteract the effect of a disease-causing gene. They may explain why some people with genetic mutations linked to severe disease […]

Mogrify has won the AstraZeneca Life Science Innovation category of the Business Weekly Awards. The award commends Mogrify in applying its proprietary direct cellular conversion technology to further the cause of life science discovery for the benefit of human healthcare. Prof. Julian Gough, Co-founder and CSO of Mogrify, received the Cambridge Enterprise Academic Entrepreneur of […]

IDBS has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst Software. This expands on IDBS’s existing family of integrations. This new integration aims to strengthen IDBS’ existing preclinical capabilities by seamlessly transferring data, enabling increased regulatory compliance and improved throughput. In response to the call for improved preclinical workflows […]